美国 · SEC FORM 4
Monopar Therapeutics
MNPR · Nasdaq · CIK 0001645469 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
46 同一窗口内观察到的 Form 4 交易行
26 sales · 20 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-12-26 · Vu Quan Anh.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 1,086,279
- 上期报告
- 844,226
- 日均成交量
- 180,448
- 回补天数
- 6.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-12-26 | Vu Quan Anh | 买入 (P) | Common Stock | 1,500 | USD 69.95 | USD 104,925 | SEC 申报 ↗ |
| 2024-10-28 | Radhakrishnan Karthik | 买入 (P) | Common Stock | 1,550 | USD 16.25 | USD 25,188 | SEC 申报 ↗ |
| 2024-06-20 | Cittadine Andrew | 买入 (P) | Common Stock | 20,508 | USD 0.74 | USD 15,176 | SEC 申报 ↗ |
| 2024-06-18 | Cittadine Andrew | 买入 (P) | Common Stock | 12,000 | USD 0.86 | USD 10,320 | SEC 申报 ↗ |
| 2024-06-17 | Cittadine Andrew | 买入 (P) | Common Stock | 12,000 | USD 0.90 | USD 10,800 | SEC 申报 ↗ |
| 2024-06-14 | Cittadine Andrew | 买入 (P) | Common Stock | 12,000 | USD 0.93 | USD 11,160 | SEC 申报 ↗ |
| 2024-06-13 | Cittadine Andrew | 买入 (P) | Common Stock | 12,000 | USD 0.91 | USD 10,920 | SEC 申报 ↗ |
| 2024-06-04 | Cittadine Andrew | 买入 (P) | Common Stock | 12,000 | USD 0.78 | USD 9,360 | SEC 申报 ↗ |
| 2024-06-03 | Cittadine Andrew | 买入 (P) | Common Stock | 12,000 | USD 0.76 | USD 9,120 | SEC 申报 ↗ |
| 2024-05-31 | Cittadine Andrew | 买入 (P) | Common Stock | 12,000 | USD 0.64 | USD 7,680 | SEC 申报 ↗ |
| 2024-05-30 | Cittadine Andrew | 买入 (P) | Common Stock | 12,000 | USD 0.64 | USD 7,680 | SEC 申报 ↗ |
| 2024-05-29 | Cittadine Andrew | 买入 (P) | Common Stock | 12,000 | USD 0.64 | USD 7,680 | SEC 申报 ↗ |
| 2022-11-15 | Cittadine Andrew | 买入 (P) | Common Stock | 10,000 | USD 3.15 | USD 31,500 | SEC 申报 ↗ |
| 2022-11-14 | Cittadine Andrew | 买入 (P) | Common Stock | 6,053 | USD 3.00 | USD 18,159 | SEC 申报 ↗ |
Form 4 申报证据
55 transaction lines in the latest 365-day window; 268 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | STARR CHRISTOPHER M | 卖出 (S) | Common Stock | 8,400 | USD 78.50 | USD 659,387 | SEC 申报 ↗ |
| 2026-10-01 | STARR CHRISTOPHER M | 期权行权／转换 (M) | Common Stock | 8,400 | USD 0.01 | USD 42 | SEC 申报 ↗ |
| 2026-09-30 | Vu Quan Anh | 期权行权／转换 (M) | Common Stock | 614 | USD — | USD — | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | STARR CHRISTOPHER M | 卖出 (S) | Common Stock | 8,400 | USD 78.50 | USD 659,387 | SEC 申报 ↗ |
| 2026-10-01 | STARR CHRISTOPHER M | 期权行权／转换 (M) | Common Stock | 8,400 | USD 0.01 | USD 42 | SEC 申报 ↗ |
| 2026-09-30 | Vu Quan Anh | 期权行权／转换 (M) | Common Stock | 614 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-30 | Vu Quan Anh | 代扣税 (F) | Common Stock | 180 | USD 79.67 | USD 14,341 | SEC 申报 ↗ |
| 2026-09-30 | Robinson Chandler | 期权行权／转换 (M) | Common Stock | 9,801 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-30 | Robinson Chandler | 代扣税 (F) | Common Stock | 4,344 | USD 79.67 | USD 346,086 | SEC 申报 ↗ |
| 2026-09-30 | Cittadine Andrew | 期权行权／转换 (M) | Common Stock | 4,384 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-30 | Cittadine Andrew | 代扣税 (F) | Common Stock | 1,944 | USD 79.67 | USD 154,878 | SEC 申报 ↗ |
| 2026-09-24 | Robinson Chandler | 卖出 (S) | Common Stock | 29,056 | USD 88.00 | USD 2,556,851 | SEC 申报 ↗ |
| 2026-09-24 | Robinson Chandler | 期权行权／转换 (M) | Common Stock | 29,056 | USD 21.74 | USD 631,680 | SEC 申报 ↗ |
| 2026-08-26 | Tsuchimoto Kim R | 卖出 (S) | Common Stock | 4,090 | USD 111.39 | USD 455,567 | SEC 申报 ↗ |
| 2026-08-26 | Tsuchimoto Kim R | 期权行权／转换 (M) | Common Stock | 4,090 | USD 22.04 | USD 90,140 | SEC 申报 ↗ |
| 2026-08-26 | Tsuchimoto Kim R | 卖出 (S) | Common Stock | 4,090 | USD 111.39 | USD 455,567 | SEC 申报 ↗ |
| 2026-08-26 | RIOUX PATRICE | 卖出 (S) | Common Stock | 1 | USD 111.26 | USD 111 | SEC 申报 ↗ |
| 2026-08-26 | RIOUX PATRICE | 期权行权／转换 (M) | Common Stock | 1,380 | USD 0.01 | USD 14 | SEC 申报 ↗ |
| 2026-08-25 | Anderson Raymond | 卖出 (S) | Common Stock | 3,142 | USD 111.98 | USD 351,835 | SEC 申报 ↗ |
| 2026-08-25 | Anderson Raymond | 期权行权／转换 (M) | Common Stock | 3,142 | USD 30.00 | USD 94,260 | SEC 申报 ↗ |
| 2026-08-25 | Anderson Raymond | 卖出 (S) | Common Stock | 3,142 | USD 111.77 | USD 351,189 | SEC 申报 ↗ |
| 2026-06-30 | Vu Quan Anh | 期权行权／转换 (M) | Common Stock | 1,228 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-30 | Vu Quan Anh | 代扣税 (F) | Common Stock | 507 | USD 92.59 | USD 46,943 | SEC 申报 ↗ |
| 2026-06-30 | Robinson Chandler | 期权行权／转换 (M) | Common Stock | 12,873 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-30 | Robinson Chandler | 代扣税 (F) | Common Stock | 4,084 | USD 92.59 | USD 378,138 | SEC 申报 ↗ |
| 2026-06-30 | Cittadine Andrew | 期权行权／转换 (M) | Common Stock | 5,254 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-30 | Cittadine Andrew | 代扣税 (F) | Common Stock | 2,309 | USD 92.59 | USD 213,790 | SEC 申报 ↗ |
| 2025-12-31 | Robinson Chandler | 期权行权／转换 (M) | Common Stock | 8,724 | USD — | USD — | SEC 申报 ↗ |
| 2025-12-31 | Robinson Chandler | 代扣税 (F) | Common Stock | 2,558 | USD 65.30 | USD 167,037 | SEC 申报 ↗ |
| 2025-12-31 | Cittadine Andrew | 期权行权／转换 (M) | Common Stock | 4,326 | USD — | USD — | SEC 申报 ↗ |
| 2025-12-31 | Cittadine Andrew | 代扣税 (F) | Common Stock | 1,889 | USD 65.30 | USD 123,352 | SEC 申报 ↗ |
| 2025-12-26 | Vu Quan Anh | 买入 (P) | Common Stock | 1,500 | USD 69.95 | USD 104,925 | SEC 申报 ↗ |
| 2025-12-18 | KLAUSNER ARTHUR J | 卖出 (S) | Common Stock | 5,121 | USD 67.15 | USD 343,889 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | MNPR |
| CIK | 0001645469 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 268 transaction lines from 2020-03-31 to 2026-10-01 14 P purchase lines · 38 S sale lines · 216 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.